MAR 25, 2021 10:00 AM PDT

Cancer Biomarkers in the Breath

Sponsored by: Agilent
Speaker

Abstract
Date:  March 25, 2021
Time: 10:00am (PST),  1:00pm (EST)
 
Linus Pauling not only won two Nobel prizes, he opened up a new field of research when he reported the first microanalysis of human breath 50 years ago. Using the then-new technology of gas chromatography, he discovered that concentrated human breath contains a multitude of different volatile organic compounds (VOCs) in low concentrations (ppb). We now know that a single sample of breath contains more than 2,000 different VOCs, and these VOCs contain biomarkers of several diseases including lung cancer, breast cancer, radiation exposure, and infections such as tuberculosis and influenza. Breath VOC analysis is technically difficult: the sample must be collected without background contamination, and then analyzed with high sensitivity and resolution using advanced separation methods. Every clinical research study generates a torrent of data that require sophisticated informatics management, and the database must then be mined for concealed signals of disease, a task that resembles searching for a few grains of gold in a mountain of rubble. Investigators at Menssana Research have developed methods for collecting breath samples to rapidly analyze breath VOCs. Our clinical research studies have shown that many diseases appear to have their own unique “fingerprint” of breath VOCs, including biomarker VOCs that are downstream metabolic products of oxidative stress. In clinical research studies, breath biomarkers identified breast cancer and lung cancer, and predicted abnormal cancer imaging with a mammogram and a chest CT.
 
 
For Research Use Only. Not for use in diagnostic procedures.
 
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
LIVE NOW!
C.E. CREDITS
LIVE NOW!
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
MAR 30, 2021 8:00 AM PDT
MAR 30, 2021 8:00 AM PDT
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
Loading Comments...
Show Resources